← Leaderboards
Mitchell Robert Knisely
University Of Illinois At Chicago
$1,282,265
Attributed
$7,844,922
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,844,922 · 3
By mechanism
UH3$6,352,490 · 1
R01$1,049,682 · 1
R21$442,750 · 1
Top collaborators
- Ardith Z Doorenbos4 shared
- Miriam Omelebele Ezenwa4 shared
- Robert E Molokie4 shared
- Judith Michelle Schlaeger4 shared
- Nirmish R Shah4 shared
- Diana J Wilkie4 shared
- Allison E Ashley-Koch3 shared
- Nadine Matthie2 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Judith Michelle Schlaeger$4,439,333
- Jimmy Orjala$6,101,964
- Guido F Pauli$8,225,012
- Holli A Devon$3,820,591
- Robert E Molokie$2,244,680
Others in their field
Other Emerging Leaders on “Pain”
- Abraham Aizer Brody · New York University School Of Medicine$25,530,786
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Barbara Burtness · Yale University$11,235,253
- William Russell Renthal · Brigham And Women'S Hospital$11,023,625
Research focus
PainSickle Cell AnemiaCharacteristicsChronicUnited StatesUniversitiesPersonsDesignDepressive SymptomsSymptomsPain ManagementUnited States National Institutes Of HealthResponseAcuteChronic PainHospitalizationHealth Care CostsOpioidSiteAnxietyAdaptive InterventionComplementary TherapiesAlternative TherapiesAccident And Emergency Department
Grant awards (7)
Advancing a Holistic Understanding of Variability in Lived Experience with Sickle Cell Pain$1,049,682
R01 · FY2025 · HL
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,584,065
UH3 · FY2024 · AT
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,582,439
UH3 · FY2023 · AT
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease$201,250
R21 · FY2023 · NR · contact PI
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,573,843
UH3 · FY2022 · AT
Epigenetic Age Acceleration and Psychoneurological Symptoms in Sickle Cell Disease$241,500
R21 · FY2022 · NR · contact PI
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain$1,612,143
UH3 · FY2021 · AT